Tuesday, Vaxcyte, Inc. (NASDAQ:PCVX) released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the company's 31-valent pneumococcal conjugate ...

Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious diseases including COVID, the flu, whooping cough, and respiratory syncytial ...

U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ...

“The [authors] took advantage of a very clean system—human volunteer inoculation,” said microbiologist Martin Blaser of the New York University Langone Medical Center who was not involved in the study ...

Surgical infections could primarily be caused by bacteria that already live on your skin, rather than via external contamination, according to a study of just over 200 people who underwent spinal ...